A1 Journal article (refereed)
Hyperspectral Imaging Reveals Spectral Differences and Can Distinguish Malignant Melanoma from Pigmented Basal Cell Carcinomas : A Pilot Study (2021)


Räsänen, J., Salmivuori, M., Pölönen, I., Grönroos, M., & Neittaanmäki, N. (2021). Hyperspectral Imaging Reveals Spectral Differences and Can Distinguish Malignant Melanoma from Pigmented Basal Cell Carcinomas : A Pilot Study. Acta Dermato-Venereologica, 101(2), Article adv00405. https://doi.org/10.2340/00015555-3755


JYU authors or editors


Publication details

All authors or editorsRäsänen, Janne; Salmivuori, Mari; Pölönen, Ilkka; Grönroos, Mari; Neittaanmäki, Noora

Journal or seriesActa Dermato-Venereologica

ISSN0001-5555

eISSN1651-2057

Publication year2021

Volume101

Issue number2

Article numberadv00405

PublisherSociety for Publication of Acta Dermato-Venereologica

Publication countrySweden

Publication languageEnglish

DOIhttps://doi.org/10.2340/00015555-3755

Publication open accessOpenly available

Publication channel open accessOpen Access channel

Publication is parallel published (JYX)https://jyx.jyu.fi/handle/123456789/75240


Abstract

Pigmented basal cell carcinomas can be difficult to distinguish from melanocytic tumours. Hyperspectral imaging is a non-invasive imaging technique that measures the reflectance spectra of skin in vivo. The aim of this prospective pilot study was to use a convolutional neural network classifier in hyperspectral images for differential diagnosis between pigmented basal cell carcinomas and melanoma. A total of 26 pigmented lesions (10 pigmented basal cell carcinomas, 12 melanomas in situ, 4 invasive melanomas) were imaged with hyperspectral imaging and excised for histopathological diagnosis. For 2-class classifier (melanocytic tumours vs pigmented basal cell carcinomas) using the majority of the pixels to predict the class of the whole lesion, the results showed a sensitivity of 100% (95% confidence interval 81–100%), specificity of 90% (95% confidence interval 60–98%) and positive predictive value of 94% (95% confidence interval 73–99%). These results indicate that a convolutional neural network classifier can differentiate melanocytic tumours from pigmented basal cell carcinomas in hyperspectral images. Further studies are warranted in order to confirm these preliminary results, using larger samples and multiple tumour types, including all types of melanocytic lesions.


Keywordsskin cancerbasal cell carcinomadiagnosticsspectral imagingmachine learningneural networks (information technology)

Free keywordsdeep learning; neural network; basal cell carcinoma; malignant melanoma


Contributing organizations


Ministry reportingYes

VIRTA submission year2021

JUFO rating2


Last updated on 2024-12-10 at 09:30